Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro.
D000613:Aminobutyrates / Q000378:metabolism*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004305:Dose-Response Relationship, Drug; D005475:Flupenthixol / Q000494:pharmacology; D005476:Fluphenazine / Q000494:pharmacology; D066298:In Vitro Techniques; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D013373:Substance P / Q000378:metabolism; D013378:Substantia Nigra / Q000187:drug effects* / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D000613:Aminobutyrates; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D013373:Substance P; D005680:gamma-Aminobutyric Acid; D003994:Bucladesine; D011189:Potassium Chloride; D005475:Flupenthixol; D005476:Fluphenazine; D002118:Calcium; D004298:Dopamine